Gao X, Ding J, Xie J, Xu H
Acta Pharmacol Sin. 2025; .
PMID: 40069488
DOI: 10.1038/s41401-025-01499-6.
Ji Y, Xiao C, Fan T, Deng Z, Wang D, Cai W
Mol Cancer. 2025; 24(1):66.
PMID: 40038722
PMC: 11881328.
DOI: 10.1186/s12943-025-02255-4.
Fan Y, Wang Y, Dan W, Zhang Y, Nie L, Ma Z
Nat Cell Biol. 2025; .
PMID: 40033101
DOI: 10.1038/s41556-025-01610-3.
Huang D, Rezaeian A, Wang J, Qi Y, Chen H, Inuzuka H
J Cancer Biol. 2025; 5(2):44-60.
PMID: 40018367
PMC: 11867627.
DOI: 10.46439/cancerbiology.5.064.
Fung T, Ryu K, Thompson C
EMBO J. 2025; 44(5):1275-1293.
PMID: 39920310
PMC: 11876448.
DOI: 10.1038/s44318-025-00379-3.
Discovery of novel PRMT1 inhibitors: a combined approach using AI classification model and traditional virtual screening.
Zhang J, Ren Y, Teng Y, Wu H, Xue J, Chen L
Front Chem. 2025; 13:1548812.
PMID: 39906150
PMC: 11788407.
DOI: 10.3389/fchem.2025.1548812.
Interspecies interactions mediated by arginine metabolism enhance the stress tolerance of against .
Zhou Z, Yang M, Fang H, Niu Y, Lu J, Ma Y
Microbiol Spectr. 2025; 13(3):e0223524.
PMID: 39868792
PMC: 11878013.
DOI: 10.1128/spectrum.02235-24.
Potential prognostic and predictive biomarkers: METTL5, METTL7A, and METTL7B expression in gastrointestinal cancers.
Heydari S, Peymani M, Hashemi M, Ghaedi K, Entezari M
Mol Biol Rep. 2025; 52(1):151.
PMID: 39847131
DOI: 10.1007/s11033-024-10207-2.
Blockade of AR improved brain perfusion and cognitive function in a mouse model of Alzheimer's disease.
Udo M, Zaccarelli-Magalhaes J, Clemons G, Citadin C, Langman J, Smith D
Geroscience. 2025; .
PMID: 39843732
DOI: 10.1007/s11357-025-01526-8.
Biomedical effects of protein arginine methyltransferase inhibitors.
Cao M, Nguyen T, Song J, Zheng Y
J Biol Chem. 2025; 301(3):108201.
PMID: 39826691
PMC: 11871472.
DOI: 10.1016/j.jbc.2025.108201.
Molecular Characterization and Potential Inhibitors Prediction of Protein Arginine Methyltransferase-2 in Carcinoma: An Insight from Molecular Docking, ADMET Profiling and Molecular Dynamics Simulation Studies.
Hossen M, Islam M, Pramanik M, Rahman M, Al Amin M, Antora S
Euroasian J Hepatogastroenterol. 2025; 14(2):160-171.
PMID: 39802857
PMC: 11714102.
DOI: 10.5005/jp-journals-10018-1443.
PRMT5 inhibition has a potent anti-tumor activity against adenoid cystic carcinoma of salivary glands.
Mishra V, Singh A, Korzinkin M, Cheng X, Wing C, Sarkisova V
J Exp Clin Cancer Res. 2025; 44(1):11.
PMID: 39794830
PMC: 11724466.
DOI: 10.1186/s13046-024-03270-x.
Therapeutic targeting potential of the protein lysine and arginine methyltransferases to reverse cancer chemoresistance.
Micallef I, Fenech K, Baron B
Front Mol Biosci. 2024; 11:1455415.
PMID: 39703687
PMC: 11656028.
DOI: 10.3389/fmolb.2024.1455415.
Targeting PRMT1 Reduces Cancer Persistence and Tumor Relapse in EGFR- and KRAS-Mutant Lung Cancer.
Sun X, Kumbier K, Gayathri S, Steri V, Wu L, Altschuler S
Cancer Res Commun. 2024; 5(1):119-127.
PMID: 39699269
PMC: 11747858.
DOI: 10.1158/2767-9764.CRC-24-0389.
PRMT1-mediated methylation regulates MLL2 stability and gene expression.
An D, Kim J, Moon B, Kim H, Nguyen H, Park S
Nucleic Acids Res. 2024; 53(4).
PMID: 39698834
PMC: 11879031.
DOI: 10.1093/nar/gkae1227.
A review of the known MTA-cooperative PRMT5 inhibitors.
Hu M, Chen X
RSC Adv. 2024; 14(53):39653-39691.
PMID: 39691229
PMC: 11650783.
DOI: 10.1039/d4ra05497k.
PRMT5/WDR77 Enhances the Proliferation of Squamous Cell Carcinoma via the ΔNp63α-p21 Axis.
Liang H, Fisher M, Wu C, Ballon C, Sun X, Mills A
Cancers (Basel). 2024; 16(22).
PMID: 39594744
PMC: 11592282.
DOI: 10.3390/cancers16223789.
Metabolites and metabolism in vascular calcification: links between adenosine signaling and the methionine cycle.
Behzadi P, St Hilaire C
Am J Physiol Heart Circ Physiol. 2024; 327(6):H1361-H1375.
PMID: 39453431
PMC: 11588312.
DOI: 10.1152/ajpheart.00267.2024.
PRMT5: splicing up tolerance.
Kumar R, Ranganathan P
J Clin Invest. 2024; 134(20).
PMID: 39403925
PMC: 11473145.
DOI: 10.1172/JCI185701.
The methionine cycle and its cancer implications.
Tassinari V, Jia W, Chen W, Candi E, Melino G
Oncogene. 2024; 43(48):3483-3488.
PMID: 39394448
DOI: 10.1038/s41388-024-03122-0.